Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
March 14, 2020
Discovery of 9-phenylacridinediones as highly selective butyrylcholinesterase inhibitors through structure-based virtual screening
Jacques Joubert, Erika Kapp
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Thabo Brighton Makgoba, Jacques Joubert, Erika Kapp
Frontiers in Pharmacology
|
October 1, 2025
Dual GSK3β/SIRT1 modulators for Alzheimer's: mechanisms, drug discovery and future perspectives
Afeez I Kareem, Erika Kapp, Jacques Joubert, et al.
Expert Opinion on Therapeutic Patents
|
June 14, 2024
HDAC3 inhibitors: a patent review of their broad-spectrum applications as therapeutic agents
Thabo Brighton Makgoba, Erika Kapp, Samuel Egieyeh, et al.
Mini Reviews in Medicinal Chemistry
|
May 13, 2017
Small Molecule Efflux Pump Inhibitors in Mycobacterium tuberculosis: A Rational Drug Design Perspective
Erika Kapp, Sarel F Malan, Jacques Joubert, et al.
Plos One
|
November 27, 2018
Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c
Ruben Cloete, Erika Kapp, Jacques Joubert, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 22, 2018
Adamantane amine-linked chloroquinoline derivatives as chloroquine resistance modulating agents in Plasmodium falciparum
Opute M Yvette, Sarel F Malan, Dale Taylor, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 3, 2015
Implementation and Operational Research: A Comparison of Two Task-Shifting Models of Pharmaceutical Care in Antiretroviral Treatment Programs in South Africa
Geoffrey Fatti, Lizette Monteith, Najma Shaikh, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2016
Polycyclic amines as chloroquine resistance modulating agents in Plasmodium falciparum
Jacques Joubert, Erika Kapp, Dale Taylor, et al.
Current Drug Delivery
|
June 9, 2026
Investigating FadD32 as a Target for 7-Substituted Coumarin Derivatives and Other Potential Antimycobacterial Agents
Sean Shamido, Jacques Joubert, Samantha Sampson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Bioorganic & Medicinal Chemistry Letters
|
March 14, 2020
Discovery of 9-phenylacridinediones as highly selective butyrylcholinesterase inhibitors through structure-based virtual screening
Jacques Joubert, Erika Kapp
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Drug Development
Thabo Brighton Makgoba, Jacques Joubert, Erika Kapp
Frontiers in Pharmacology
|
October 1, 2025
Dual GSK3β/SIRT1 modulators for Alzheimer's: mechanisms, drug discovery and future perspectives
Afeez I Kareem, Erika Kapp, Jacques Joubert, et al.
Expert Opinion on Therapeutic Patents
|
June 14, 2024
HDAC3 inhibitors: a patent review of their broad-spectrum applications as therapeutic agents
Thabo Brighton Makgoba, Erika Kapp, Samuel Egieyeh, et al.
Mini Reviews in Medicinal Chemistry
|
May 13, 2017
Small Molecule Efflux Pump Inhibitors in Mycobacterium tuberculosis: A Rational Drug Design Perspective
Erika Kapp, Sarel F Malan, Jacques Joubert, et al.
Plos One
|
November 27, 2018
Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c
Ruben Cloete, Erika Kapp, Jacques Joubert, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 22, 2018
Adamantane amine-linked chloroquinoline derivatives as chloroquine resistance modulating agents in Plasmodium falciparum
Opute M Yvette, Sarel F Malan, Dale Taylor, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 3, 2015
Implementation and Operational Research: A Comparison of Two Task-Shifting Models of Pharmaceutical Care in Antiretroviral Treatment Programs in South Africa
Geoffrey Fatti, Lizette Monteith, Najma Shaikh, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 3, 2016
Polycyclic amines as chloroquine resistance modulating agents in Plasmodium falciparum
Jacques Joubert, Erika Kapp, Dale Taylor, et al.
Current Drug Delivery
|
June 9, 2026
Investigating FadD32 as a Target for 7-Substituted Coumarin Derivatives and Other Potential Antimycobacterial Agents
Sean Shamido, Jacques Joubert, Samantha Sampson, et al.
Page
of 2